Competition watchdog mulls changes to financial penalty calculation system

Fines will be aligned with international standards.

The Competition Commission of Singapore is seeking feedback on proposed changes to financial penalty guidelines.

During public consultations in 2015, the CCS received feedback that penalty guidelines should be amended so that the calculation of fines is based on revenue for the financial year preceding the date when the undertaking’s participation in the infringement ended.

At present, the regulator calculates penalties based on the turnover for the financial year preceding the date on which the decision of the CCS is taken.

The CCS has also reviewed its process with regard to the issuance of Proposed Infringement Decisions. The watchdog proposes to clarify in the Enforcement Guidelines that, in line with CCS’s practice, the proposed amount of financial penalty will be set out in the PID so as to permit addressees of the PID to make written and oral representations to CCS on matters of liability as well as penalty.
 

Join Singapore Business Review community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Top News

DBS and OCBC expected to deliver steady Q1 net profits
Their net interest margins will ease as a result of their Hong Kong loans.
Singapore's maritime cluster navigates towards digital, green future
Adapting to emerging challenges, such as the adoption of alternative fuels, is deemed crucial for the country's maritime sector.
SCG and A*STAR unveil joint labs for cellular immunotherapy enhancement
The partnership has a funding of nearly $30m supported under Singapore's Research, Innovation and Enterprise 2025 plan.
Healthcare